This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cardiovascular Disease
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

ClarityIQ is a novel X-ray imaging technology, that combines advanced real-time image noise reduction algorithms, with state-of-the-art hardware to reduce patient entrance dose significantly. This is realized by anatomy-specific optimization of the full acquisition chain (grid switch, beam filtering, pulse width, spot size, detector and image processing engine) for every clinical task individually. Furthermore, smaller focal spot sizes, shorter pulses and the introduction of automatic real-time motion compensation in subtraction imaging are used, which are known to positively influence image quality . The final effect on the clinical image quality in peripheral angiography is investigated in this study.

Provided treatments

  • Radiation: Low-dose DSA (83% reduction compared to normal dose) with novel X-ray imaging technology.
  • Radiation: Normal dose DSA with conventional X-ray imaging technology
Tris trial is registered with FDA with number: NCT01599741. The sponsor of the trial is Philips Healthcare and it is looking for 51 volunteers for the current phase.
Official trial title:
Clinical Validation and Evaluation of X-ray Image Processing for Endovascular Digital Subtraction Angiography and Intervention